Stemtech Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Stemtech Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $4.92M | Jul 10, 2024 |
| FY2023 | Dec 31, 2022 | $4.56M | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | $4.32M | Apr 17, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.05M | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | $4.92M | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | $4.56M | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | $4.32M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $4.38M | Apr 1, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.77M) | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | ($5.43M) | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | ($8.54M) | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | ($7.08M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($916.7K) | Apr 1, 2022 |
| FY2020 | Aug 31, 2020 | ($34.4K) | Dec 14, 2020 |
| FY2020 | Aug 31, 2019 | ($33.8K) | Dec 14, 2020 |
| FY2019 | Aug 31, 2018 | ($37.3K) | Dec 13, 2019 |
| FY2018 | Aug 31, 2017 | ($46.3K) | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | ($28.4K) | Dec 14, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.39M) | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | ($4.22M) | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | ($5.02M) | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | ($3.21M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.43M) | Apr 1, 2022 |
| FY2020 | Aug 31, 2020 | ($18.9K) | Dec 14, 2020 |
| FY2020 | Aug 31, 2019 | ($20.2K) | Dec 14, 2020 |
| FY2019 | Aug 31, 2018 | ($24.8K) | Dec 13, 2019 |
| FY2018 | Aug 31, 2017 | ($36.5K) | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | ($23.5K) | Dec 14, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.78M | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | $3.68M | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | $4.27M | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | $5.72M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $5.01M | Apr 1, 2022 |
| FY2020 | Aug 31, 2020 | $46.4K | Dec 14, 2020 |
| FY2020 | Aug 31, 2019 | $2.9K | Dec 14, 2020 |
| FY2019 | Aug 31, 2018 | $14.8K | Dec 13, 2019 |
| FY2018 | Aug 31, 2017 | $17.1K | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | $9.6K | Dec 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $9.01M | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | $6.46M | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | $7.44M | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | $9.73M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.74M | Apr 1, 2022 |
| FY2020 | Aug 31, 2020 | $272.2K | Dec 14, 2020 |
| FY2020 | Aug 31, 2019 | $194.3K | Dec 14, 2020 |
| FY2019 | Aug 31, 2018 | $172.4K | Dec 13, 2019 |
| FY2018 | Aug 31, 2017 | $137.4K | Dec 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($4.48M) | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | ($2.04M) | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | ($2.43M) | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | ($3.36M) | Apr 17, 2023 |
| FY2020 | Aug 31, 2020 | ($225.8K) | Dec 14, 2020 |
| FY2020 | Aug 31, 2019 | ($191.4K) | Dec 14, 2020 |
| FY2020 | Aug 31, 2018 | ($157.6K) | Dec 14, 2020 |
| FY2019 | Aug 31, 2017 | ($120.3K) | Dec 13, 2019 |
| FY2018 | Aug 31, 2016 | ($94.0K) | Dec 14, 2018 |
| FY2017 | Aug 31, 2015 | ($65.6K) | Dec 14, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jul 10, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 1, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $132.5K | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $828.2K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $133.1K | Apr 1, 2022 |
| FY2020 | Aug 31, 2020 | $2.2K | Dec 14, 2020 |
| FY2020 | Aug 31, 2019 | $714 | Dec 14, 2020 |
| FY2019 | Aug 31, 2018 | $8.2K | Dec 13, 2019 |
| FY2018 | Aug 31, 2017 | $8.6K | Dec 14, 2018 |
| FY2018 | Aug 31, 2016 | $3.7K | Dec 14, 2018 |
| FY2017 | Aug 31, 2015 | $819 | Dec 14, 2017 |
| FY2016 | Aug 31, 2014 | $18.1K | Dec 8, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.82M | Jun 30, 2025 |
| FY2024 | Dec 31, 2023 | $3.49M | Jun 30, 2025 |
| FY2023 | Dec 31, 2022 | $929.1K | Jul 10, 2024 |